Stock listing
Daito Pharmaceutical Co., Ltd.
Selected listing: 4577 · TSE · JPY · JP
Daito Pharmaceutical Co., Ltd. (Tokyo:4577), Health Technology. Latest release Sep 30, 2026: Execution of JV and Share Transfer Agreement for Transfer…
- Ticker
- Tokyo:4577
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Tokyo
- Currency
- JPY
About Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. is a public company listed under the ticker 4577 in the Japanese market. Daito focuses on the development and production of pharmaceutical products, contributing to advancements in healthcare.
Latest news from Daito Pharmaceutical Co., Ltd.
Execution of JV and Share Transfer Agreement for Transfer of KYORIN Pharmaceutical's Generic Drug Business to JV by Daito, Meiji Seika Pharma and DBJ
September 30, 2026
FY2026 4Q Earnings Presentation
July 15, 2026
Notice Regarding the Results and Completion of the Acquisition of Treasury Shares Through Off-Auction Own Share Repurchase Transaction (ToSTNet-3)
July 12, 2026
Summary of Consolidated Financial Results for the Fiscal Year Ended May 31,2026 (Under Japanese GAAP)
July 10, 2026
PeptiDream Announces First Dosing of Claudin18.2 Targeting Radiopharmaceutical Candidate 64Cu-PD-29875 in Patients with Gastric Cancer
June 11, 2026
Research Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. company profile
View the public company page for Daito Pharmaceutical Co., Ltd. on 6ix.
Daito Pharmaceutical Co., Ltd. news
Read company news and market updates connected to Daito Pharmaceutical Co., Ltd..
Daito Pharmaceutical Co., Ltd. investor events
Find investor webinars, events, and replay context for Daito Pharmaceutical Co., Ltd..